Ingevity Overview
- Year Founded
-
1964
- Status
-
Public
- Employees
-
1,500
- Stock Symbol
-
NGVT
- Investments
-
13
- Share Price
-
$53.75
- (As of Friday Closing)
Ingevity General Information
Description
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
Contact Information
Website
www.ingevity.comCorporate Office
- 4920 O'Hear Avenue
- Suite 400
- North Charleston, SC 29405
- United States
Corporate Office
- 4920 O'Hear Avenue
- Suite 400
- North Charleston, SC 29405
- United States
Ingevity Stock Performance
As of 20-Nov-2026, Ingevity’s stock price is $53.75. Its current market cap is $1.82B with 33.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $53.75 | $55.96 | $48.00 - $79.28 | $1.82B | 33.8M | 313K | $1.79 |
Ingevity Financials Summary
As of 30-Sep-2026, Ingevity has a trailing 12-month revenue of $1.13B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,571,138 | 3,336,451 | 2,902,026 | 3,168,040 |
| Revenue | 1,132,300 | 1,167,600 | 1,200,100 | 1,215,500 |
| EBITDA | 197,000 | 37,000 | 57,500 | 339,200 |
| Net Income | 59,800 | (167,100) | (430,300) | (5,400) |
| Total Assets | 1,503,400 | 1,651,100 | 2,022,600 | 2,623,300 |
| Total Debt | 1,178,800 | 1,242,700 | 1,449,000 | 1,534,500 |
Ingevity Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ingevity Comparisons
Industry
Financing
Details
Ingevity Competitors (17)
One of Ingevity’s 17 competitors is Imerys, a Formerly PE-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Imerys | Formerly PE-Backed | Paris, France | ||||
| Arkema | Corporation | La Défense, France | ||||
| Entegris | Corporation | Billerica, MA | ||||
| Cabot | Corporation | Boston, MA | ||||
| Solvay | Corporation | Brussels, Belgium |
Ingevity Patents
Ingevity Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026213132-A1 | Hard carbon-coated lithium metal anodes | Pending | 31-Mar-2025 | ||
| US-20260249228-A1 | Adsorbent and systems for direct air capture | Pending | 24-Feb-2025 | ||
| WO-2026187540-A2 | Adsorbent and systems for direct air capture | Pending | 24-Feb-2025 | ||
| AU-2024435740-A1 | Applications of oxidized lignin in agricultural formulations | Pending | 20-Mar-2024 | ||
| US-20250296898-A1 | Applications of oxidized lignin in agricultural formulations | Pending | 20-Mar-2024 | B01J20/28004 |
Ingevity Signals
Ingevity Investments & Acquisitions (13)
Ingevity’s most recent deal was a Later Stage VC with Interface Polymers for . The deal was made on 27-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Interface Polymers | 27-Mar-2023 | Later Stage VC | Specialty Chemicals | ||
| Ozark Materials | 03-Oct-2022 | Merger/Acquisition | Specialty Chemicals | ||
| Nexeon | 03-Aug-2022 | PE Growth/Expansion | Other Commercial Products | ||
| MITO (Materials) | 04-Feb-2022 | Seed Round | Other Materials | ||
| Aqdot | 20-Nov-2021 | Later Stage VC | Specialty Chemicals |
Ingevity ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
30 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Chemicals
Industry
of 503
Rank
Percentile
Specialty Chemicals
Subindustry
of 165
Rank
Percentile
Ingevity Exits (4)
Ingevity’s most recent exit was on 27-Mar-2023 from Interface Polymers. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Interface Polymers | 27-Mar-2023 | Completed |
|
||
| Ozark Materials | 03-Oct-2022 | Completed |
|
||
| MITO (Materials) | 04-Feb-2022 | Completed |
|
||
| GreenGasUSA Holdings | 27-Apr-2021 | Corporate | Completed |
Ingevity Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Ingevity Arkansas | Crossett, AR | 2017 |
Ingevity FAQs
-
When was Ingevity founded?
Ingevity was founded in 1964.
-
Where is Ingevity headquartered?
Ingevity is headquartered in North Charleston, SC.
-
What is the size of Ingevity?
Ingevity has 1,500 total employees.
-
What industry is Ingevity in?
Ingevity’s primary industry is Specialty Chemicals.
-
Is Ingevity a private or public company?
Ingevity is a Public company.
-
What is Ingevity’s stock symbol?
The ticker symbol for Ingevity is NGVT.
-
What is the current stock price of Ingevity?
As of 20-Nov-2026 the stock price of Ingevity is $53.75.
-
What is the current market cap of Ingevity?
The current market capitalization of Ingevity is $1.82B.
-
What is Ingevity’s current revenue?
The trailing twelve month revenue for Ingevity is $1.13B.
-
Who are Ingevity’s competitors?
Imerys, Arkema, Entegris, Cabot, and Solvay are some of the 17 competitors of Ingevity.
-
What is Ingevity’s annual earnings per share (EPS)?
Ingevity’s EPS for 12 months was $1.79.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process